Group Visits for Patients with Enlarges Prostates: Enhancing Patient Care, Cutting Wait Times – Evidence from a Study Comparing Shared Appointments to One-on-One Sessions.

Phase 3

• Conditions: Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

• Registration Number: CTRI/2024/01/061605
• Lead Sponsor: Priyank Yadav

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

We will have the following inclusion criteria:

1. The patient must be 50 years or older.

2. The patient must have regular visits at Urology Clinic in SGPGIMS.

3. The patients should have come for follow up visits only, requiring no examination.

4. The patient should not have any symptoms requiring admission or any procedure with or without anaesthesia.

5. International Prostate Symptom Score (IPSS) of eight or more.

6. The patient should not require surgical intervention in the near future.

7. The patient must not wish to interact with a specific doctor.

Exclusion Criteria

We will have the following exclusion criteria:

1. Any physical or mental conditions in the patient or accompanying persons that preclude interaction in a group setting.

2. Participation of the patient in any other existing trial.

3. The patient had not indwelling catheters, urinary incontinence, anuria, gross haematuria, acute urinary retention, urinary tract infection, and prostate cancer.

4. Any patient who needs clinical examination will be excluded for reasons of privacy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Patient waiting time <br/ ><br>2. Patient consultation timeTimepoint: All primary outcomes will be measured at 0 and 6 months

Secondary Outcome Measures

Name	Time	Method
1. Patient anxiety <br/ ><br>2. Patient knowledge <br/ ><br>3. Patient satisfaction <br/ ><br>4. Engagement in SMA <br/ ><br>5. Doctor’s productivity <br/ ><br>Timepoint: Secondary outcome will be measured at 0 and 6 months